55
Views
0
CrossRef citations to date
0
Altmetric
Review

Future of Cardiac Resynchronization Therapy

, &
Pages 191-201 | Published online: 28 Feb 2008

Bibliography

  • Lambiase PD , RinaldiCA, HauckJet al.: Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy. Heart, 90, 44–51 (2004).
  • Shamim W , FrancisDP, YousafuddinMet al.: Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int. J. Cardiol., 70, 171–178 (1999).
  • Auricchio A , AbrahamWT: Cardiac resynchronisation therapy: current state of the art.Circulation, 109, 300–307 (2004).
  • Leclercq C , FarisO, EvansFet al.: Systolic improvement and mechanical resynchronisation does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation, 106, 1760–1763 (2002).
  • Khaykin Y , SaadEB, WilkoffBL: Pacing in heart failure: the benefit of resynchronisation.Cleve. Clin. J. Med., 70, 841–864 (2003).
  • Nelson GS , BergerRD, FeticsBJet al.: Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation, 102, 3053–3059 (2000).
  • Kim WY , SogaardP, MortensenPTet al.: Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure. Heart, 85, 514–520 (2001).
  • Auricchio A , SpinelliJC, TrautmannSIet al.: Effect of resynchronisation therapy on ventricular remodelling. J. Card. Fail., 8, S549–S555 (2002).
  • St John Sutton MG , PlappertTet al., Abraham WT : Effect of cardiac resynchronisation therapy on left ventricular size and function in chronic heart failure patients. Circulation, 107, 1985–1990 (2003).
  • Sogaard P , EgebaldH, PedersenAKet al.: Sequential versus simultaneous biventricular resynchronisation for severe heart failure: evaluaition by tissue Doppler imaging. Circulation, 106, 2078–2084 (2002).
  • Shenkman HJ , PampatiVet al., Khandelwal AK : Congestive heart failure and QRS duration: establishing prognosis study. Chest, 122, 528–534 (2002).
  • Grassi G , VincentiA, BrambillaRet al.: Sustained sympathoinhibitory effects of cardiac resynchronisation therapy in severe heart failure. Hypertension, 44, 727–731 (2004).
  • Cleland JGF , DaubertJC, ErdmannEet al.: The effect of cardiac resynchronisation on morbidity and mortality in heart failure. N. Engl. J. Med., 352, 1539–1549 (2005).
  • Sinha AM , SkobelEC, MarkusKUet al.: Cardiac Resynchronisation Therapy improves central sleep apnoea and Cheyne-Stokes respiration in patients with chronic heart failure. J. Am. Coll. Cardiol., 44, 68–71 (2004).
  • Bakker P , MeijburgH, DeJongheNet al.: Beneficial effects of biventricular pacing in congestive heart failure. Pacing Clin. Electrophysiol., 17, 820 (1994).
  • Cazeau S , RitterP, BakdachSet al.: Four chamber pacing in dilated cardiomyopathy. Pacing Clin. Electrophysiol., 17, 1974–1979 (1994).
  • Auricchio A , StellbrinkC, SackSet al.: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol., 39(12), 2026–2033 (2002).
  • Auricchio A , StellbrinkC, ButterCet al.: Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J. Am. Coll. Cardiol., 42, 2109–2116 (2003).
  • Bristow MR , SaxonLA, BoehmerJet al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med., 350, 2140–2150 (2004).
  • Cazeau S , LeclercqC, LavergneTet al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med., 344, 873–880 (2001).
  • Higgins SL , HummelJD, NiaziIKet al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol., 42, 1454–1459 (2003).
  • Young JB , AbrahamWT, SmithALet al.: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA, 289, 2685–2694 (2003).
  • Abraham WT , FisherWG, SmithALet al.: Cardiac resynchronization in chronic heart failure. N. Engl. J. Med., 346, 1845–1853 (2002).
  • Vardas PE , AuricchioA, BlancJJet al.: Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur. Heart J., 28, 2256–2295 (2007).
  • Yu CM , AbrahamWT, BaxJet al.; and on behalf of the PROSPECT investigators: Predictors of Response to Cardiac Resynchronisation Therapy (PROSPECT) study design. Am. Heart J., 149, 600–605 (2005).
  • Bleeker GB , HolmanER, SchalijMJet al.: Cardiac resynchronization therapy in patients with a narrow QRS complex. J. Am. Coll. Cardiol., 48, 2243–2250 (2006).
  • Yu CM , ChanYSet al., Lam YY : Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J. Am. Coll. Cardiol., 48, 2251–2257 (2007).
  • Beshai JF , GrimmRA, NaguehSFet al.: Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N. Engl. J. Med., 357, 2461–2471 (2007).
  • Thambo JB , BordacharP, GarrigueSet al.: Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation, 110, 3766–3772 (2004).
  • Nielsen JC , AndersenHR, ThomsenPEet al.: Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation, 97, 987–995 (1998).
  • Maurer G , TorresMA, CordayE, HaendchenRV, MeerbaumS: Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: relation to altered regional left ventricular function.J. Am. Coll. Cardiol., 3, 986–991 (1984).
  • The DAVID Trial Investigators: Dual-chamber pacing or ventricular backup pacing in patientswith an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288, 3115–3123 (2002).
  • Sweeney MO , HellkampASet al., Ellenbogen KA ; for the MOST iInvestigators: Adverse effect of ventricular pacing on heart failure and atrial fibrillation mong patients with normal baseline QRS duration in a clinical trial of pacemaker for sinus node dysfunction. Circulation, 107, 2932–2937 (2003).
  • Curtis AB , AdamsonPB, ChungEet al.; for the BLOCK HF study group: Biventricular versus right ventricular pacing in patients with AV block – clinical study design and rationale. J. Cardiovasc. Electrophysiol., 18, 965–971 (2007).
  • Funck RC , BlancJJ, MuellerHH, Schad-BrittingerC, Bailleul C; for the BioPace Study Group: Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)‘ study. Europace, 8, 629–635 (2006).
  • Etienne Y , MansouratiJ, LurieKGet al.: Evaluation of left ventricle based pacing in patients with congestive heart failure and atrial fibrillation. Am. J. Cardiol., 83, 1138–1140 (1999).
  • Hay I , MelenovskyV, BergerRDet al.: Short-term effects of right–left heart sequential cardiac resynchronisation in patients with heart failure,chronic atrial fibrillation and atrioventricular nodal block. Circulation, 110, 3404–3410 (2004).
  • Delnoy PP , OttervangerJP, MisierARet al.: Comparison of usefulness of cardiac resynchronisation therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am. J. Cardiol., 99, 1252–1257 (2007).
  • Kadish A , DyerA, DaubertJPet al.; for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) investigators: pProphylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med., 35, 2151–2158 (2004).
  • Lam SK , OwenA: Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.Br. Med. J., 335(7626), 925 (2007).
  • Rossillo A , VermaA, SaadEBet al.: Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J. Cardiovasc. Electrophysiol., 15, 36 (2004).
  • Auricchio A , StellbrinkC, SackSet al.: Long term clinical effect of haemodynamically optimised cardiac resynchronisation therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol., 39, 2026–2033 (2002).
  • Sogaard P , EgebaldH, PedersenAKet al.: Sequential versus simultaneous biventricular resynchronisation for severe heart failure: evaluaition by tissue Doppler imaging. Circulation, 106, 2078–2084 (2002).
  • Abraham WT , YoungJB, LeonARet al.: Effects of cardiac resynchronization therapy on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter defibrillator, and mildly symptomatic chronic heart failure. Circulation, 110, 2864–2868 (2004).
  • Linde C , GoldMR, AbrahamWT, Daubert JC: Rationale and design of a randomised controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure – the Resynchronization Reverses Remodeling in Systolic Systolic Left Ventricular Dysfunction (REVERSE) study. Am. Heart J., 151, 288–294 (2006).
  • Kawara T , DerksenR, de Groot JR: Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation, 104, 3069–3075 (2001).
  • Bleeker GB , KaandorpTAM, LambHJet al.: Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation, 113, 969–976 (2006).
  • Kim RJ , WuE, RafaelAet al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med., 343(20), 1445–1453 (2000)
  • van Campen CM , VissserFC, VisserCAet al.: FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur. J. Nucl. Med. Mol. Imaging, 34(3), 309–315 (2007).
  • Chiribiri A , KelleS, GotzeSet al.: Visualization of the cardiac venous system using cardiac magnetic resonance. Am. J. Cardiol., 101(3), 407–412 (2008).
  • Van Campen CMC , VisserFCet al., de Cock CC : Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment; need for individualisation of lead localisation. Heart, 92, 1795–1800 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.